Aspect Biosystems

Biotech · Private

Microfluidic 3D bioprinting platform for creating human tissue models and engineered tissues

aspectbiosystems.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
23
9 granted · 14 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2862E AND B TECHNOLOGIES, LLC——
2863BRILLIANT BIOSCIENCES INC.——
2864TEO THERAPEUTICS INCORPORATED——
2865Aspect Biosystems——
2866KOMMODO THERAPEUTICS LLC——
2867VIVOSPHERE LLC——
2868BETASTEM THERAPUETICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 9 granted of 23

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.